MGQSX
Price
$20.90
Change
-$0.12 (-0.57%)
Updated
Sep 20 closing price
RWIBX
Price
$66.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

MGQSX vs RWIBX

Header iconMGQSX vs RWIBX Comparison
Open Charts MGQSX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Stars R6
Price$20.90
Change-$0.12 (-0.57%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R2
Price$66.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGQSX vs RWIBX Comparison Chart
Loading...
VS
MGQSX vs. RWIBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGQSX is a Buy and RWIBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 128B vs. MGQSX (77.5M). RWIBX pays higher dividends than MGQSX: RWIBX (1.05) vs MGQSX (0.48). MGQSX was incepted earlier than RWIBX: MGQSX (11 years) vs RWIBX (22 years). MGQSX is a more actively managed with annual turnover of: 34.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than MGQSX: RWIBX (250) vs MGQSX (5000000). MGQSX (24.68) and RWIBX (23.75) have marching annual gain over last year. MGQSX return over 5 years is better than : 51.75 vs. RWIBX (42.68).
MGQSXRWIBXMGQSX / RWIBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years22 years-
Gain YTD13.52513.562100%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets77.5M128B0%
Annual Yield % from dividends0.481.0546%
Returns for 1 year24.6823.75104%
Returns for 3 years14.367.37195%
Returns for 5 years51.7542.68121%
Returns for 10 years83.5549.04170%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.940.75
+17.90%
Genfit SA
NNI112.94-2.01
-1.75%
Nelnet
ILMN131.14-3.25
-2.42%
Illumina
SPRB0.44-0.01
-2.59%
Spruce Biosciences
APLT7.70-0.30
-3.75%
Applied Therapeutics